Revealed: how this common gut microbe protects against heart disease
Atherosclerosis involves the build up of fatty plaque (yellow) in the walls of arteries, limiting the flow of…
Thyroid Medication Recall Elevated to Highest Warning Level: FDA
NEED TO KNOW The FDA has elevated the recall of a thyroid medication to Class I, due to…
This mysterious lung disease affects millions of people — but a drug tested in mice shows promise
X-ray shows scarring in the lungs that occurs in people with idiopathic pulmonary fibrosis.Credit: SPL A mysterious lung…
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
World-first stem-cell therapy shows promise for treating spina bifida in the womb
An in utero treatment using placenta-derived stem cells could treat infants with a neural-tube condition called spina bifida.…
How some COVID vaccines triggered rare blood-clot disorder
Many countries changed their advice about who should have the AstraZeneca vaccine (pictured) following reports it could trigger…
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
Longevity therapeutics market to double by 2033
Global longevity therapeutics market projected to hit US$43.72b by 2033, as supplements and antiaging solutions move from niche…
‘Giant step forward’ for Huntington’s — the scientist behind the first gene therapy
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers…
Single antivenom protects against 17 different snakebites
The black mamba is one Africa’s most deadly venomous snakes.Credit: Matthijs Kuijpers/Alamy An antivenom using antibodies from a…
Elevara Medicines Raises $70 Million Series A to Advance
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and WeatherdenInnovative lead program, ELV001, in-licensed…
Why simply ending animal testing isn’t the answer in biomedical research
A polarized debate in biomedical research is pitting those who favour ‘traditional animal models’ — meaning living non-human…